Medtronic Inc. (MDT), one of the world’s largest medical-device makers, was sued by Humana Inc. for allegedly marketing its Infuse bone-graft product for uses that weren’t approved by regulators and duping the insurer into covering those claims.
Medtronic paid doctors hundreds of millions of dollars to tout the safety and effectiveness of the Infuse product for a variety of spinal surgeries even though the U.S. Food and Drug Administration had limited its use to lower-back procedures, Humana said in a complaint filed May 30 in federal court in Tennessee.
